Literature DB >> 22855343

Excitotoxicity through NMDA receptors mediates cerebellar granule neuron apoptosis induced by prion protein 90-231 fragment.

Stefano Thellung1, Elena Gatta, Francesca Pellistri, Alessandro Corsaro, Valentina Villa, Massimo Vassalli, Mauro Robello, Tullio Florio.   

Abstract

Prion diseases recognize, as a unique molecular trait, the misfolding of CNS-enriched prion protein (PrP(C)) into an aberrant isoform (PrP(Sc)). In this work, we characterize the in vitro toxicity of amino-terminally truncated recombinant PrP fragment (amino acids 90-231, PrP90-231), on rat cerebellar granule neurons (CGN), focusing on glutamatergic receptor activation and Ca(2+) homeostasis impairment. This recombinant fragment assumes a toxic conformation (PrP90-231(TOX)) after controlled thermal denaturation (1 h at 53 °C) acquiring structural characteristics identified in PrP(Sc) (enrichment in β-structures, increased hydrophobicity, partial resistance to proteinase K, and aggregation in amyloid fibrils). By annexin-V binding assay, and evaluation of the percentage of fragmented and condensed nuclei, we show that treatment with PrP90-231(TOX), used in pre-fibrillar aggregation state, induces CGN apoptosis. This effect was associated with a delayed, but sustained elevation of [Ca(2+)]i. Both CGN apoptosis and [Ca(2+)]i increase were not observed using PrP90-231 in PrP(C)-like conformation. PrP90-231(TOX) effects were significantly reduced in the presence of ionotropic glutamate receptor antagonists. In particular, CGN apoptosis and [Ca(2+)]i increase were largely reduced, although not fully abolished, by pre-treatment with the NMDA antagonists APV and memantine, while the AMPA antagonist CNQX produced a lower, although still significant, effect. In conclusion, we report that CGN apoptosis induced by PrP90-231(TOX) correlates with a sustained elevation of [Ca(2+)]i mediated by the activation of NMDA and AMPA receptors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855343     DOI: 10.1007/s12640-012-9340-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  72 in total

1.  Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity.

Authors:  D R Brown; W J Schulz-Schaeffer; B Schmidt; H A Kretzschmar
Journal:  Exp Neurol       Date:  1997-07       Impact factor: 5.330

2.  Stress-protective signalling of prion protein is corrupted by scrapie prions.

Authors:  Angelika S Rambold; Veronika Müller; Uri Ron; Nir Ben-Tal; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

3.  Channel formation by a neurotoxic prion protein fragment.

Authors:  M C Lin; T Mirzabekov; B L Kagan
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

4.  Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.

Authors:  Alessandro Corsaro; Stefano Thellung; Valentina Villa; Mario Nizzari; Antonio Aceto; Tullio Florio
Journal:  OMICS       Date:  2012 Jan-Feb

5.  Truncated forms of the human prion protein in normal brain and in prion diseases.

Authors:  S G Chen; D B Teplow; P Parchi; J K Teller; P Gambetti; L Autilio-Gambetti
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

6.  In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.

Authors:  Joëlle Chabry; Christiane Ratsimanohatra; Isabelle Sponne; Pierre-Paul Elena; Jean-Pierre Vincent; Thierry Pillot
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

7.  Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.

Authors:  Baptiste A Faucheux; Nicolas Privat; Jean-Philippe Brandel; Véronique Sazdovitch; Jean-Louis Laplanche; Claude-Alain Maurage; Jean-Jacques Hauw; Stéphane Haïk
Journal:  J Neuropathol Exp Neurol       Date:  2009-08       Impact factor: 3.685

8.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

9.  Uptake and pathogenic effects of amyloid beta peptide 1-42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists.

Authors:  X Bi; C M Gall; J Zhou; G Lynch
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

10.  Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein.

Authors:  A Corsaro; S Thellung; C Russo; V Villa; S Arena; M C D'Adamo; D Paludi; D Rossi Principe; G Damonte; U Benatti; A Aceto; F Tagliavini; G Schettini; T Florio
Journal:  Neurochem Int       Date:  2002-07       Impact factor: 3.921

View more
  11 in total

1.  Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells.

Authors:  Valentina Villa; Stefano Thellung; Alessandro Corsaro; Federica Novelli; Bruno Tasso; Luca Colucci-D'Amato; Elena Gatta; Michele Tonelli; Tullio Florio
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

2.  Different Molecular Mechanisms Mediate Direct or Glia-Dependent Prion Protein Fragment 90-231 Neurotoxic Effects in Cerebellar Granule Neurons.

Authors:  Stefano Thellung; Elena Gatta; Francesca Pellistri; Valentina Villa; Alessandro Corsaro; Mario Nizzari; Mauro Robello; Tullio Florio
Journal:  Neurotox Res       Date:  2017-05-25       Impact factor: 3.911

3.  Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment.

Authors:  Minghai Zhou; Gregory Ottenberg; Gian Franco Sferrazza; Christopher Hubbs; Mohammad Fallahi; Gavin Rumbaugh; Alicia F Brantley; Corinne I Lasmézas
Journal:  Brain       Date:  2015-02-11       Impact factor: 13.501

4.  Nicotinic receptor activation contrasts pathophysiological bursting and neurodegeneration evoked by glutamate uptake block on rat hypoglossal motoneurons.

Authors:  Silvia Corsini; Maria Tortora; Andrea Nistri
Journal:  J Physiol       Date:  2016-08-03       Impact factor: 5.182

5.  Meet the editor series-Massimo Vassalli.

Authors:  Massimo Vassalli
Journal:  Biophys Rev       Date:  2021-02-01

Review 6.  Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity.

Authors:  Stefanie A G Black; Peter K Stys; Gerald W Zamponi; Shigeki Tsutsui
Journal:  Front Cell Dev Biol       Date:  2014-08-28

7.  Unique structural properties associated with mouse prion Δ105-125 protein.

Authors:  Avnish Patel; Snezana Vasiljevic; Ian M Jones
Journal:  Prion       Date:  2013 May-Jun       Impact factor: 3.931

8.  Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells.

Authors:  Alessandro Corsaro; Adriana Bajetto; Stefano Thellung; Giulia Begani; Valentina Villa; Mario Nizzari; Alessandra Pattarozzi; Agnese Solari; Monica Gatti; Aldo Pagano; Roberto Würth; Antonio Daga; Federica Barbieri; Tullio Florio
Journal:  Oncotarget       Date:  2016-06-21

9.  Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death.

Authors:  Stefano Thellung; Beatrice Scoti; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Maria Cristina Gagliani; Carola Porcile; Claudio Russo; Aldo Pagano; Carlo Tacchetti; Katia Cortese; Tullio Florio
Journal:  Cell Death Dis       Date:  2018-02-07       Impact factor: 8.469

Review 10.  Cellular Prion Protein (PrPc): Putative Interacting Partners and Consequences of the Interaction.

Authors:  Hajar Miranzadeh Mahabadi; Changiz Taghibiglou
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.